Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?

OLUKMAN, MURAT; CAN, CENK; EROL, AYŞE; ÖKTEM, GÜLPERİ; ORAL, ONUR; CINAR, Mehtap

Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?

Atıf İçin Kopyala

OLUKMAN M. , CAN C. , EROL A. , ÖKTEM G. , ORAL O. , CINAR M. G.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.9, ss.260-266, 2009 (SCI İndekslerine Giren Dergi)

Cilt numarası: 9 Konu: 4
Basım Tarihi: 2009
Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
Sayfa Sayıları: ss.260-266

Özet

Objective: The natural antioxidant, resveratrol has been suggested to protect against doxorubicin-induced cardiotoxicity. Although derangements in nitric oxide (NO) synthesis contribute to vascular endothelial dysfunction caused by doxorubicin, the effects of resveratrol on these parameters have not been evaluated yet. We investigated the impact of resveratrol on doxorubicin-induced vascular dysfunction in rat thoracic aorta with regard to NO synthesis in an experimental, prospective, controlled study.